Reviewed Jun 2026 · policies are checked weekly for changes · stated — every cell is read from 23andMe's published policy; none has been tested (run by us) yet.
1Deletionstated
Account deletion is self-serve and irreversible on email confirmation, but 23andMe "and/or our contracted genotyping laboratory will retain your Genetic Information, date of birth, and sex" as required under the federal Clinical Laboratory Improvement Amendments (CLIA), and any research "already performed or published" before withdrawal cannot be reversed.
23andMe — Privacy Statement (full version, CLIA retention) · accessed Jun 2026 ↗
1Sells / sharesstated
23andMe does not sell individual-level genetic data and research is opt-in, but its US privacy disclosures acknowledge that sharing identifiers with advertising partners for cross-context behavioral advertising "may constitute a 'sale' or 'sharing' of personal information" under the CCPA (opt-out via Cookie Choices / Global Privacy Control).
23andMe — How We Use Information (US Privacy) · accessed Jun 2026 ↗
1Trains AIstated
The privacy statement references deriving information via algorithms or machine learning but contains no explicit statement either prohibiting model training on personal or genetic data or offering an AI-training opt-out separate from the opt-in research consent — the AI-training question is unaddressed.
23andMe — Privacy Statement (full version) · accessed Jun 2026 ↗
§Enforcement action — deducts 4 points (severity 2); data practices without the penalty scored C (8/12)verified
A 2023 breach exposed data on 6.9 million users, leading to a $30 million US class-action settlement and a £2.31 million fine from the UK's ICO in June 2025 for failing to protect users' genetic data.
UK Information Commissioner's Office · 17 Jun 2025 ↗
All cells are "stated" (sourced to 23andMe's current privacy statement and help-center docs, last updated May 19 2026; not yet live-tested). Provenance: 23andMe's assets were acquired by TTAM Research Institute — a nonprofit founded by co-founder Anne Wojcicki — for $305M after the March 2025 Chapter 11 filing (sale closed ~July 14 2025). TTAM committed to honor the existing privacy policies, stand up a Consumer Privacy Advisory Board, and bar any future sale or transfer of genetic data to a recipient that does not adopt the same commitments.